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Title Page
ABSTRACT 
Study design: Prospective observation study  
 
Objective: To identify the relationship between obesity, quantified by body mass index (BMI), and 
both back and leg pain in spinal patients. 
 
Summary of Background Data: Obesity and back pain are massive public health problems. Given the 
poor correlation between pain and an pathological change in the spine in the spine, further 
investigation is required into other, non-pathological, predictors such as obesity.  
 
Methods: The Genodisc Study was one of the largest cross-sectional studies of patients presenting to 
tertiary spinal units and recruited from six centres in four European countries. In total, 2636 patients 
were recruited over a 5-year period between 2008 and 2013. Both back and leg pain were scored by 
patients in the range of 0 to 10. Linear regression was used to model the relationship between BMI 
and pain. Potential confounders included in the model were: age, Zung Depression score, episodes of 
sport, gender, disability benefit, family history, previous surgery, smoking status, work type, clinical 
diagnosis and relevant co-morbidities. Back and leg pain outcomes were modelled separately.  
 
Results:  The study included 1160 men and 1349 women with a mean age of 50.9 years and mean BMI 
of 27.2kg/m2. In our fully adjusted model, a 5-point increase in BMI was associated with greater leg 
(0.19 units [95% CI 0.08,0.31]) but not back (0.10 units [95% CI -0.02,0.22]) pain scores. Although this 
relationship was statically significant, given the small magnitude of the relationship, the clinical 
significance is limited. Similarly, female gender, heavy workload, rheumatoid arthritis, previous spine 
surgery and depression were associated with higher back and leg pain.  
 
Structured Abstract (300 words)
Conclusion: In this large observational study of spine patients presenting to tertiary European 
centres, obesity, as measured by increased body mass index, was associated with greater leg pain.  
Key Words: low back pain; sciatica; leg pain; obesity; body mass index; epidemiology 
KEY POINTS 
1. An increase in BMI was associated with higher back (non-significant) and leg pain 
(significant) scores. 
2. Other factors that were associated with greater BP or LP were female gender, previous spine 
surgery, heavy workload, rheumatoid arthritis and depression. 
3. Back pain was associated with a greater number of significant predictors than LP possibly 
because it is an umbrella term for poorly defined conditions. 
Key Points (3-5 main points of the article)
MINI ABSTRACT 
The analysis of 2636 patients presenting to tertiary European spine centres showed an increase in 
BMI was associated with higher back (non-significant) and leg pain (significant) scores. Other factors 
that were associated with greater BP or LP were female gender, previous spine surgery, heavy 
workload, rheumatoid arthritis and depression. 
 
Mini Abstract (50 words)
Obesity, back and leg pain 
 1 
INTRODUCTION 
 
Obesity and back pain are massive public health problems. The 2010 Global Burden of Diseases Study 
found low back pain to be the leading cause of disability worldwide with a global point prevalence of 
9.4-11.9%.[1, 2] As an outcome of the Global Burden of Diseases Study, there has been an urgent call 
for further research to understand the predictors of low back pain.[1, 3] 
 
Given the poor correlation between pain and an pathological change in the spine in the spine,[4] 
further investigation is required into other, non-pathological, predictors such as obesity. From 
population-based studies, it has been established that BMI increases the odds of low back and leg 
pain.[5, 6] However, these studies consider pain as a binary outcome and provide little information 
for the effect of obesity upon the severity of pain. Furthermore, there is limited information as to the 
relationship between BMI and pain in the patient population seen in a tertiary care setting. It is 
important to understand the contributors to back and leg pain in this population, as these are the 
patients who present to surgeons, rheumatologists and physiotherapists daily.  
 
The primary aim of our study was to define a relationship between obesity and both low back (BP) 
and leg pain (LP) scores separately in a large population of patients presenting to tertiary spine 
centres. We also present data on other predictors of low back and leg pain.  
 
PATIENTS AND METHODS 
Genodisc Study Design 
Patients were recruited as part of the pan-European Genodisc study[7] All patients presenting to six 
tertiary spine care centres in four countries; UK, Hungary, Slovenia and Italy, were invited to 
participate. In total, 2636 patients were recruited over a 5-year period (2008-2013).   
Manuscript Text (must include page numbers)
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Pain Scores 
The Genodisc Participant Survey collected patient reported information for both back and leg pain. It 
specifically asked participants to rate their pain experienced in the preceding week and score it on an 
scale ranging from 0, meaning no pain, to 10 being the worst pain imaginable. Back pain was defined 
as pain in the lower back. Participants were asked to score LP that went below their knee, in an 
attempt to differentiate true radicular LP from other causes, such as hip osteoarthritis. 
 
Other Participant Data 
Demographic and patient reported information including age, gender, height and weight (from which 
BMI was calculated), co-morbidities, smoking status, occupation, family history, previous surgery and 
disability benefit were also collected. As an assessment of mood, participants were also asked to 
complete the Zung Self Reported Depression Score (Zung).  
 
Statistical Methods 
Stata 13.1 (Stata, College Station, Tx, USA) was used for all statistical analysis. Univariate analysis was 
initially performed. For the multivariate models, the predictor variable was BMI. The outcome 
variables, BP and LP scores were modelled separately as continuous variables. Other confounders 
included in the model were age, Zung Depression score, number of sporting activities per week, 
gender, disability benefit, family history, previous surgery, smoking status, work type, clinical 
diagnoses (disc herniation, spinal stenosis, spondylolisthesis and non-specific back pain) and co-
morbidities (rheumatoid arthritis, osteoarthritis, osteoporosis, fibromyalgia, migraine, irritable bowel 
syndrome, anxiety, hypertension, diabetes and cancer). Multiple imputation has been shown to be a 
valid method in overcoming missing data [8] and was used to overcome incomplete data. 
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RESULTS  
 
Table 1 describes the Genodisc population which contained information on 2636 patients. BMI was 
normally distributed with a mean of 27.11kg/m2. The median (interquartile range [IQR]) duration of 
symptoms was 10 (4-24) months for BP and 8 (3-20) months of LP. Underweight (BMI<18 kg/m2) and 
morbidly obese (BMI>35 kg/m2) patients presented after a longer duration of both back and leg pain 
when compared to other patients (Figure 1a). 
 
Increasing BMI was associated with higher unadjusted BP and LP scores (Table 2). It is important to 
note the marked increase in the prevalence of hypertension and diabetes with increasing BMI.  
 
Table 3 shows the main result of the univariate and multivariate linear regression models. Multivariate 
adjusted model 1 for BP shows that a 5-point increase in BMI was associated with a non-significant 
increase in BP score of 0.20 units (95% CI -0.02, 0.22). However in the univariate model, this 
association was significant. To investigate where this relationship was lost in our multivariate model, 
we sequentially removed individual confounders. When hypertension and diabetes were removed 
(Back pain multivariate adjusted model 2), the effect of BMI upon BP remained significant at 0.15 units 
(95% CI 0.04,0.27) with minimal change to the coefficients of the other confounders.  
 
In the multivariate model for LP, a 5-point increase in BMI was associated with a 0.19 unit (95% CI 
0.15,0.31) increase in pain (Table 3). There was very little change in this effect with the removal of 
hypertension and diabetes from our regression model (Leg pain multivariate adjusted model 2;Table 
3). Figure 2 graphically represents the adjusted linear effect of increasing BMI upon back and leg pain.  
 
The regression coefficients with associated confidence intervals from multivariate model for both back 
and leg pain are illustrated in Figure 3. Female gender, depression (Zung Depression Score), 
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 4 
rheumatoid arthritis, heavy workload and previous surgery were all significant positive predictors of 
both increased BP and LP. Sport was a significant negative predictor for both BP (-0.07 [95% CI -0.14,-
0.01]) and LP (-0.10 [95% CI -0.14,-0.04]). Specifically, for BP, the strongest positive predictors were 
receiving benefit for disability (0.67 units [95% CI 0.30, 1.04]), a heavy workload (0.67 units [95% CI 
0.33,1.01]) and rheumatoid arthritis (0.72 units [95% CI 0.33,1.11]). By contrast, the strongest 
association for LP was a diagnosis of lumbar disc herniation (1.08 units [95% CI 0.84,1.33]).  
 
DISCUSSION 
In this large group of spine patients presenting to European tertiary spinal units, an increase in BMI 
was associated with higher back (non-significant) and leg pain (significant) scores (Figure 2 and Figure 
3). Other factors that were associated with greater BP or LP were female gender, previous spine 
surgery, heavy workload, rheumatoid arthritis and depression (Zung Depression Score) (Figure 3). It is 
important to note that due to the cross-sectional nature of this study, we can only infer associations 
not causation.  
 
Back pain was associated with a greater number of significant predictors than LP possibly because it 
is an umbrella term for poorly defined conditions (Figure 3). Leg pain, below the knee, however, 
usually has an underlying disc herniation. This is supported in the LP model, where the diagnosis of 
disc herniation had a strong positive association increasing LP score by 1.08 units (95% CI 0.84,1.33) 
(Figure 3).  
 
In our analysis, when we considered hypertension and diabetes as confounders, we found that the 
effect of BMI upon BP score, but not LP score, was markedly weakened with minimal change in any of 
the other confounders. 
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 The relationship between the cardiovascular risk factors and spine related pain is unclear as it is 
difficult to identify a direct effect of hypertension and diabetes upon back and leg pain. Certain 
authors have described an atherosclerotic hypothesis to explain a causal relationship between 
hypertension and diabetes and BP. This relationship has been established primarily in cadaveric 
studies[9, 10] and also in an occupation-based epidemiological study.[11] Within this occupational 
study, the authors showed that over a 28-year period patients with higher blood pressure at baseline 
had increased risk of BP. This could explain why hypertension and diabetes only confound the 
relationship between BMI and BP, and not LP. 
 
It is well recognised that both hypertension and diabetes are associated with obesity as part of the 
metabolic syndrome. Our data supports a positive association between increasing prevalence of both 
diabetes and hypertension with increasing BMI (Table 2). Given this, we believe, these confounders 
most likely lie on the causal pathway between obesity and BP and hence adjusting for these may not 
be appropriate. As such we interpret the effect of hypertension and diabetes to be primarily related 
to BMI. 
 
A recent meta-analysis, by Shiri et al found that people with increased BMI had greater odds of 
developing BP, increased prevalence of BP and were more likely to have chronic BP.[6] Importantly, 
this relationship was dose dependant, with obese people having higher levels of pain than those who 
were overweight. Another recently published meta-analysis, by the same group, showed a similar 
dose dependant relationship between increasing BMI and self reported LP symptoms.[5] A limitation 
of these meta-analyses and of the original studies is that both BP and LP were considered as binary 
“yes/no” variables. Our study adds to this by showing a similar relationship exists in BP and LP for 
patients seeking tertiary care and by providing a more detailed understanding on the effect of BMI 
upon the severity of both BP and LP. 
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Shiri also noted that overweight or obese patients were more likely to “seek care” for their BP.[6] 
Based on this information we would have expected our group of patients to have a higher BMI than 
the general population. However, when we compare the mean BMI within our population (27.2 kg/m2) 
to those reported in population based studies such as the English Longitudinal Study of Aging (27.9 
kg/m2),[12] the United Kingdom Biobank (27.4 kg/m2)[13] or a large Hungarian cohort (25.9 
kg/m2),[14] there are minimal differences. This is important, as although overweight and obese people 
from the study of Shiri et al[6] appear more likely to seek primary care, based on the mean BMI in this 
study, it appears that these patients do not filter through to tertiary care. It seems unlikely that this is 
because their symptoms are less severe as we have found increased BMI is associated with more 
severe pain (Figure 2) and also with longer duration of pain symptoms, suggesting a longer period 
before tertiary care consultation (Figure1a). A hypothetical explanation could be negative institutional 
attitudes for the health care of the obese[15] could possibly lead to restriction in their access to 
tertiary level care for back and leg pain, similar to that seen in osteoarthritis.[16] 
 
Our findings for BP are similar to those of Fanuele et al, who, though not looking at pain directly, used 
the American National Spine Network data to model the effect of BMI upon disability arising from low 
back pain.[17] Here, the authors found that obesity was associated with decreased functional status 
and increased disability. Unfortunately, given the nature of their dataset the authors were not able to 
correct for depressive symptoms, a significant confounder in our study, nor did they consider LP as an 
outcome in their adjusted model. Similarly, Heuch et al recently showed, in a longitudinal study, that 
a BMI of greater than 30kg/m2 increases the odds of developing BP, further supporting the deleterious 
relationship between obesity and BP.[18] 
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As there appears a direct relationship between BMI and the severity of pain (Figure 2); the next 
question we must ask is if weight loss help reduce the pain. Recently, three separate small case-series 
of back pain patients have found that post bariatric surgery with resulting rapid weight loss, obese 
patients have less BP[19-21] and reduced spine related disability.[19, 20] Surgical weight loss 
represents an extreme form of weight loss and is a treatment that may not be widely available but 
the results support the idea that weight loss could lead to decreased pain and this requires further 
investigation. 
 
As well as weight loss, our results suggest that exercise is associated with less back pain (Figure 3). 
Within a population setting, Smuck et al, in addition to finding a dose dependant increase of BP with 
BMI, showed that moderate physical was protective from back pain in an overweight and ultraobese 
population, but not in the obese group.[22] However, when BMI was considered continuous, this study 
found physical activity conferred only a small protective effect. The Nord-Trøndelag Health study also 
found a small protective effect of physical activity upon back pain.[18] To an extent, these results are 
in keeping with our study where lower  BP and LP scores were associated with greater physical activity 
(Figure 3). More specifically, the greatest decrease in pain score was noted between patients involved 
in only one episode of sport a week as compared to those who did none (Figure 1b). Similarly, with 
increasing BMI the associated number of episodes of sporting activity decreases suggesting these 
patients are less likely to partake in potentially beneficial exercise (Table 2). Alternatively, patients 
with greater pain may be less willing to exercise so whether exercise is protective cannot be fully 
assessed from this cross-sectional data.  
 
The link between obesity and pain is usually thought to be mechanical but biochemical pathways may 
also operate. Obesity is known to cause a systemic low grade inflammatory milieu and there is growing 
evidence that there is a biochemical link between obesity, degeneration of musculoskeletal tissues 
and pain.[23] Leptin, the prototypical adipokine, is reported to increase the synthesis of pro-
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inflammatory cytokines, pain generators and destructive mediators in a knee osteoarthritis model.[24, 
25] Adipokines can elicit a similar response in the intervertebral disc, the primary joint of the spine[26] 
as well as altered pain behaviour in a lumbar nerve root compression model.[27]  
 
Obesity has also been implicated or associated in other pain and psychiatric disorders such as 
fibromyalgia,[28] migraines[29, 30] and depression.[31, 32] For patients with depression and migraine 
headaches, a similar dose dependant relationship of increasing BMI with greater symptoms is 
seen.[29, 30, 32] This linear relationship is less clear in fibromyalgia with authors suggesting an 
important relationship between obesity, physical activity and symptoms.[28] Furthermore, altered 
adipokines have also been associated with migraine headaches[30] and fibromyalgia.[33] Taken 
together, this would suggest increased BMI is an important mediator in main pain related disorders 
and the effect could be mediated by systemic rather than local mechanisms. 
 
The Genodisc Study is one of the largest populations of patients suffering from spinal conditions with 
prospectively collected data in a standardised format. As a result, the study carries considerable power 
and enables us to adjust for many potential participant and clinician reported confounders without 
limiting the validity of our results. We believe our results are generalisable within the tertiary care 
setting as patients were recruited from six sites in four countries with a resulting heterogeneous 
population. 
 
The cross sectional nature of this study raises three important caveats when interpreting the results. 
Firstly, we cannot establish causation, however within the general population, there is evidence that 
obesity may be a factor directly leading to back and leg pain.[6, 18]  
 
Secondly, the clinical relevance of these findings requires discussion. For the numerical pain rating 
scale, as used in this study, a reduction of two points or 30% is generally accepted as a clinically 
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meaningful difference.[34, 35] From our study, even a very large 15 kg/m2 increase in BMI would not 
show a clinically meaningful difference in pain score. The small coefficients seen in our study may be 
statistically enhanced by the large sample size. 
 
Although, the definition of a clinically important difference was derived from chronic pain populations 
including patients with low back and neuralgic pain, it is important to note that such difference 
represents a change in pain score, which is usually an intra-individual change within a longitudinal 
cohort or interventional study. Even though our population is similar, the interpretation of clinical 
relevance is most likely informative rather than prescriptive in our observational study. Similarly, our 
findings are consistent to what is seen in the literature suggesting a true result rather than a statically 
anomaly.  
 
Finally, pain is a symptom, which is not constant and can change because of factors other than those 
relating to a biological or pathoanatomical process. Although we attempted to acquire a more general 
picture of pain symptoms by asking participants to rate their pain over the previous week, longitudinal 
studies are required to answer the question of causation.  
 
CONCLUSION 
This study provides evidence supporting the hypothesis that obesity is independently associated with 
leg pain and that the effect of increasing BMI upon pain is linear. It also provides information on other 
clinically important predictors of pain in spine patients, in particular female gender, heavy workload, 
rheumatoid arthritis, previous spine surgery and depression. Given the growing evidence for a 
relationship between obesity and both back and leg pain, we need to move forward to understand 
the underlying biological pathway and also to define evidence-based management modalities for 
obese patients with spinal conditions. 
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TABLES  
 
Table 1: Characteristics of the Genodisc participants. Data are n (%), mean (standard 
deviation [SD]) or median (interquartile range [IQR]) 
 
 
 
 
 
 
 
 
 
  
Characteristic:  
Missing 
(n) 
Age (years), mean (SD) 50.85 (14.59) 111 
Women, n (%) 1349 (53.8%) 127 
BMI (kg/m2), mean (SD) 27.22 (4.80) 169 
Pain Score (units), mean (SD)   
 Back  6.18 (2.88) 211 
 Leg 6.66 (2.91) 217 
Duration of Symptoms (months), median (IQR)   
 Back 10 (4-24) 432 
 Leg 8 (3-20) 436 
Zung Depression Score, mean (SD) 39.83 (9.00) 942 
Sport per Week (episodes), median (IQR) 0 (0-2) 133 
Disability Benefit, n (%) 296 (12.1) 183 
Family History, n (%) 747 (30.3) 172 
Previous Surgery, n (%)  715 (27.9) 69 
Smoking Status, n (%)  264 
 Never 1079 (45.5)  
 Previous 622 (26.2)  
 Current 671 (28.3)  
Work Type, n (%)  234 
 Sedentary  684 (28.5)  
 Light  605 (25.2)  
 Medium 563 (23.4)  
 Heavy  550 (22.9)  
Clinical Diagnosis, n (%)   
 Lumbar disc herniation  1413 (55.5) 90 
 Spinal stenosis  968 (39.1) 161 
Tables
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Table 2: 
Categorised 
BMI with 
unadjusted mean low back pain and leg pain score, participation in sport and prevalence of 
hypertension and diabetes for each group. 
 
 
  
 Spondylolisthesis  400 (16.3) 186 
 Non-specific Back Pain  359 (14.7) 198 
Comorbidities , n (%)  0 
 Rheumatoid Arthritis  233 (8.8)  
 Osteoarthritis 298 (11.3)  
 Osteoporosis  180 (6.8)  
 Fibromyalgia 21 (0.8)  
 Migraine 381 (14.5)  
 Irritable Bowel Syndrome 162 (6.1)  
 Anxiety 233 (8.8)  
 Hypertension 715 (27.1)  
 Type 2 Diabetes Mellitus 214 (8.1)  
 Cancer 298 (11.3)  
 Underweight  
(<18.50) 
Normal Weight 
(18.50–24.99) 
Overweight  
(25.00–29.99) 
Obese  
(30.00–34.99) 
Severe Obese 
(≥35.00) 
Number of Patients 37 780 952 451 153 
Back pain score 
mean (95% CI) 
5.35 (4.39,6.31) 
6.00  
(5.80,6.21) 
6.16  
(5.98,6.35) 
6.24 (5.98,6.50) 
7.24 
(6.83,7.65) 
Leg pain score 
mean (95% CI) 
6.27 (5.10,7.44) 
6.42  
(6.21,6.64) 
6.57  
(6.39,6.76) 
6.97 (6.72,7.21) 
7.70 
(7.36,8.03) 
Episodes of sport  
per week 
mean (95% CI) 
1.08 (0.39,1.78) 
1.06  
(0.93,1.18) 
1.01  
(0.90,1.12) 
1.01 (0.84,1.18) 
0.72 
(0.48,0.96) 
Type 2 diabetes 
mellitus (%) 
0.0 3.9 7.4 15.0 21.3 
Hypertension (%) 10.8 14.9 27.6 45.6 53.8 
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Table 3: Univariate and multivariate regression coefficients for the effect of BMI upon back and leg pain scores. 
Multivariate model 1 includes hypertension and diabetes as confounders, multivariate model 2 does not. 
Coefficient is the regression coefficient. Each coefficient represents a change in pain score for a 5-unit increase 
in BMI. A positive coefficient represents increased pain. Models were fitted to 50 multiple imputation datasets 
(n=2636). Multivariate model 1 is adjusted for all confounders as described in the main text.  In multivariate 
model 2, hypertension and diabetes were excluded. 
 
 Back Pain Score  Leg Pain Score 
 Coefficient (95% CI) p value  Coefficient (95% CI) p value 
Univariate 0.26 (0.14,0.37) 0.0  0.35 (0.23,0.47) 0.0 
Multivariate model 1 0.10 (-0.02,0.22) 0.10  0.19 (0.08,0.31) 0.0 
Multivariate model 2 0.15 (0.04,0.27) 0.01  0.22 (0.10,0.33) 0.0 
Obesity and back/leg pain 
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FIGURE LEGENDS 
Figure 1: a) Mean duration of pain (months) experienced by patients categorised by BMI (body mass 
index). b) Mean pain scores categorised by episodes of sport. Markers represent mean and 95% 
confidence intervals. **p<0.01 when compared to a) normal BMI or b) no  sport 
Figure 2: Adjusted mean back and leg pain score for each BMI (body mass index) category. Bars 
show mean and 95% confidence Interval 
Figure 3: Confidence interval plots showing regression coefficients of multivariate model 1 (adjusted 
for hypertension and diabetes) for both the back and leg pain. Models fitted to 50 multiple imputation 
datasets (n=2636). Coefficient is the regression coefficient. A positive coefficient represents higher 
pain and a negative coefficient represents lower pain. The solid diamond represents the effect and 
the error bars the 95% confidence interval. If the confidence interval does not cross the “No Effect” 
dotted line the predictor is significant. 
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